Dear Editor: The recent report on serum anti-Müllerian hormone (AMH) levels and phenotypes of polycystic ovary syndrome is very interesting [1]. Hwang et al. [1] concluded that “high serum AMH levels cannot predict the phenotype of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients in the non-obese group”. Notably, the results from this work are totally different from ...

abstract the gnrh analogue (agonist and antagonist gnrh) changed ovarian stimulation. on the one hand, it improved chances of pregnancy to obtain more oocytes and better embryos. this leads to an ovarian hyper-response, which can be complicated by the ovarian hyperstimulation syndrome (ohss). on the other hand, the gnrh analogue can prevent the incidence of ohss: gnrh antagonist protocols, gnrh...

OBJECTIVE To review the clinical aspects of ovarian hyperstimulation syndrome and provide recommendations on its diagnosis and clinical management. OUTCOMES These guidelines will assist in the early recognition and management of ovarian hyperstimulation. Early recognition and prompt systematic supportive care will help avert poor outcomes. EVIDENCE Medline, Embase, and the Cochrane database...

Polycystic ovary syndrome is an endocrine disorder affecting 1 in 10 women. Women with polycystic ovary syndrome can experience co-morbidities, including depressive symptoms. This research explores the experience of living with polycystic ovary syndrome and co-morbidities. Totally, 10 participants with polycystic ovary syndrome took part in Skype™ interviews and analysed using thematic analysis...

Background: Polycystic ovary syndrome is a common endocrine disorder with 3-7% prevalence in the general population and 10% in women of childbearing. This rate has increased in infertile women. The main composition of this syndrome includes anovulation or olygoovulation, clinical and laboratory signs of increased androgens and observation polycystic ovaries on ultrasound in evaluation. In this ...

background: polycystic ovarian syndrome (pcos) has been shown to cause a reduction in health-related quality of life (hrqol). objective:  this study examines the extent of different clinical symptoms in pcos patients on hrqol. materials and methods:  a cross-sectional study was undertaken to ascertain the factors related to hrqol in 200 pcos patients in kashan, iran. main outcome measures were ...

BACKGROUND Gonadotropin-releasing hormone (GnRH) agonist triggering plus 1,500 IU human chorionic gonadotropin (hCG) supplementation protocol was previously claimed effective in reducing the ovarian hyperstimulation syndrome (OHSS) incidence in high responders. METHODS This retrospective study included women with polycystic ovarian (PCO) morphology who were at high risk of OHSS and were given...

Background: Polycystic ovary syndrome (PCOS) is one of the most common causes of anovulation, infertility and hyperandrogenism in women, affecting 5-10% of women of reproductive age. Due to the ethical limitations on human experimentation, appropriate animal models that mimic many or all PCOS characteristics would facilitate research leading to improved understanding of the pathogenesis of PCOS...

Objective: To compare the efficacy of clomiphene citrate and with metformin in anovulatory infertility PCOS (polycystic ovarian syndrome (PCOS). Study Design: Randomized controlled trial. Place Duration Study: This research took place Department Gynecology Obstetrics at combined military hospital Bahawalpur. The study was carried out over a six-month period, starting on 1st November 2022 conclu...